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more thoroughly evaluated and updated in larger studies. Although the
relevance of CRP measurements in the prediction of risk of coronary heart
disease is not completely clear, research in this area has definitely sparked
interest in the inflammatory underpinnings of atherosclerosis.
Effect of an inhibitor of cholesteryl ester transfer protein on HDL
cholesterol
Brousseau ME, Schaefer EJ, Wolfe ML, et al. New Engl J Med 2004;350:
1505-15.
Conclusion: Torcetrapid, a potent inhibitor of cholesteryl ester trans-
fer protein (CETP), dramatically increases high-density lipoprotein (HDL)
cholesterol levels and also decreases low-density lipoprotein (LDL) choles-
terol levels in subjects with low HDL cholesterol levels. The effect is the
same when torcetrapid is administered alone or in combination with a statin.
Summary: This was a single-blind, placebo-controlled study examin-
ing the effects of torcetrapid on plasma lipoprotein levels in people with low
HDL cholesterol levels. There were 19 subjects with HDL levels
40mg/dL in the study. Nine of the 19 subjects were also treated with 20
mg of atorvastatin daily. All 19 subjects received placebo for 4 weeks and
then received 120 mg of torcetrapid daily for 4 weeks. Six subjects who did
not receive atorvastatin participated in a third phase of the trial, in which they
received 120 mg of torcetrapid twice daily for 4 weeks.
In the atorvastatin and non-atorvastatin cohorts treatment with 120
mg of torcetrapid daily increased HDL levels by 61% (P  .001) and 46%
(P  .001) respectively. Treatment with 120 mg of torcetrapid twice daily
increased HDL by 106% (P .001). In the atorvastatin cohort, torcetrapid
also decreased LDL cholesterol levels by 17% (P  .02). Torcetrapid also
altered the distribution of cholesterol among LDL and HDL subclasses,
resulting in increases in the mean particle size of LDL and HDL in each
cohort tested.
Comment: HDL serves as a carrier of excess cellular cholesterol in the
reverse cholesterol transport pathway and thus is believed to provide protec-
tion against development of atherosclerosis. Two different approaches cur-
rently exist to increasing HDL levels. One is infusion of apoA-1 Milano
along with phospholipids (JAMA 2003;290:2292-300). The second is use
of CETP inhibitors as illustrated in this study. Preliminary results of both
methods appear promising. Additional clinical trials will be required to
confirm efficacy of both methods of raising HDL cholesterol levels, to select
dosages for clinical use, and to establish whether medication induced eleva-
tions of HDL levels will protect against cardiovascular disease.
Late complications after ligation and bypass for popliteal aneurysm
Kirkpatrick UJ, McWilliams RG, Martin J, et al. Brit J Surg 2004;91:174-7.
Conclusion: Ligation and bypass does not always abolish flow in the
sac of a popliteal aneurysm. Continued flow in the aneurysm sac may be
associated with aneurysm expansion and late complications.
Summary: This study was a retrospective review of patients who
underwent popliteal aneurysm repair in a university hospital over a 10-year
period. Only patients with atherosclerotic aneurysms were included. Forty-
four patients (43 males, median age 72 years) were identified who had
undergone 53 primary popliteal aneurysm repairs. Seventeen popliteal an-
eurysm repairs were excluded because of primary repair with an in-line graft,
loss to follow-up, and amputation or death, leaving available for study 36
popliteal aneurysms treated by ligation and bypass in 30 patients. Patients
were brought back for ultrasound examination. Median interval from oper-
ative repair to follow up duplex ultrasound imaging was 59 (range, 1-120)
months. A significant change in aneurysm diameter between the initial
preoperative measurement and that on follow-up imaging was defined as a
diameter increase greater than 5 mm or a change greater than 20%.
Twenty-four of the 36 bypassed popliteal aneurysms did not demon-
strate any intrasac flow on duplex examination. Ten of these were known to
be thrombosed at initial presentation. Intrasac blood flow was demonstrated
with duplex imaging in 12 popliteal aneurysms at a median of 48 (range,
13-100) months following primary bypass and ligation. Eight of these 12
aneurysms with intrasac flow by duplex scanning demonstrated significant
increase in size by the criteria noted above. One 8-cm aneurysm ruptured
with the rupture occurring 54 months after primary ligation and bypass of a
3-cm popliteal aneurysm.
Comment: The study demonstrates that patent popliteal aneurysms
treated by ligation and bypass are at significant risk of delayed complications.
Persistent blood flow within the aneurysm sac occurs in nearly half of
patients. The data suggests patients with popliteal aneurysms treated by
ligation and bypass require follow-up duplex studies to confirm thrombosis
of the aneurysm sac.
Association between high serum ferritin levels in carotid atherosclerosis
in the study of health in Pomerania (SHIP)
Wolff B, Volzke H, Ludemann J, et al. Stroke 2004;35:453-7.
Conclusion: There is a relationship between serum ferritin levels and
carotid atherosclerosis that is potentiated by low-density lipoprotein (LDL)
cholesterol.
Summary: Epidemiologic studies have observed an association be-
tween iron stores and myocardial infarction (Circulation 1992;86:803-811;
Circulation 1994;89:102-8). Iron is reportedly proatherogenic because of
its ability to generate reactive oxygen species, oxidize lipoproteins, and
activate platelets. To investigate the relationship between body iron load and
cardiovascular disease, the authors assessed intima-media thickness and
plaque prevalence in carotid arteries, using high-resolution ultrasound.
There were 2443 participants in the study (1200 women; age 45-79 years).
Multivariable analysis indicated serum ferritin levels were not indepen-
dently associated with carotid intima-media thickness in men or women.
There was a relationship between serum ferritin levels and carotid plaque
prevalence among men but not women (odds ratio per 1-SD increase of
serum ferritin levels, 1.33; 95% confidence interval, 1.08-1.44 for men).
Both men and women did show a dose response relationship between serum
ferritin levels and carotid atherosclerosis. Higher serum ferritin levels were
associated with greater odds ratios for carotid plaque prevalence. In men the
association of serum ferritin levels with carotid plaque prevalence became
stronger with increasing LDL cholesterol levels.
Comment: The study demonstrated a synergistic relationship in which
the magnitude of association between serum ferritin levels and carotid
atherosclerosis becomes greater with higher LDL cholesterol levels. This
suggests some mechanism whereby iron interferes with lipid metabolism.
While there is a certain level of biologic plausibility to such an interaction,
the overall data supporting a relationship between serum ferritin levels and
atherosclerosis still seems a bit weak. Any relationship is likely to be over-
whelmed by the effects of more traditional risk factors such as hypercholes-
terolemia, smoking and diabetes.
Major lower extremity amputation: Outcome of a modern series
Aulivola B, Hile CN, Hamdan AD, et al. Arch Surg 2004;139:395-9.
Conclusion: Major amputation of the lower extremity continues to
result in significant morbidity and mortality. Long-term survival is dismal in
patients with diabetes and end-stage renal disease requiring above-knee
amputation (AKA).
Summary: This was a retrospective analysis of 959 consecutive major
lower extremity amputations performed in 788 patients at an academic
tertiary care medical center from Jan 1, 1990, to Dec 31, 2001. Mean
follow-up was 33.6 months. The data was analyzed for patient survival,
operative morbidity, and re-amputation.
There were 704 below-knee amputations (BKAs) and 255 AKAs
performed. The overall 30-day mortality was 8.6% and was worse for AKA
(16.5%) than BKA (5.7%), P  .001. Patients requiring guillotine amputa-
tion to control sepsis had a higher mortality rate than patients undergoing
closed amputation (14.3% vs 7.8%, P  .03). Cardiac complications oc-
curred in 10.2% of patients and wound infections occurred in 5.5% of
patients. Re-operation was required in 4.7% of AKAs and 18.4% of BKAs.
Sixty-six of 129 re-operated BKAs required conversion to an AKA. Patient
survival at 1 and 5 years was 69.7% and 34.7% overall. Patients undergoing
AKA had worse survival than those undergoing BKA (50.6% vs 74.5% at 1
year and 22.5% vs 37.8% at 5 years, P  .001). Five-year survival in patients
with diabetes was 30.9% vs 51.0% in patients without diabetes, P  .002).
Five-year survival in patients with end-stage renal disease was 14.4% versus
42.2% in patients without renal failure.
Comment: This article is sobering in that it quantifies the dismal
prognosis of a group of patients who can best be described as approaching
the end of life. While the numbers are interesting, it would have been so
much more interesting to know how many patients successfully achieved
independent ambulation, how long it took to achieve complete wound
healing, and what percentage of the time of the patients’ remaining life were
they independent and able to ambulate.
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